Learn More
Medchemexpress LLC IK-175 (AHR antagonist 5 free base) | 2247950-42-9 | 99.8% | C25H24FN7 | 10MG

Supplier: Medchemexpress LLC HY14160910MG
IK-175 is an orally active, selective small-molecule antagonist of the aryl hydrocarbon receptor (AHR) developed for oncology research and clinical investigation. It modulates the tumor microenvironment and has shown target engagement and preliminary antitumor activity in early clinical studies. Supplied as a white to off-white solid for research use only.
- Selective antagonist of the aryl hydrocarbon receptor (AHR).
- Orally bioavailable candidate suitable for in vivo studies.
- Modulates the tumor microenvironment to enhance immune response.
- High supplied purity (≈99.8%).
- White to off-white solid physical form.
- High solubility in DMSO for in vitro assays.
- Powder storage recommended at low temperatures to preserve stability.
- For research use only; not for human or clinical use outside controlled studies.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.